Literature DB >> 28514612

Reversal of Autoimmune Toxicity and Loss of Tumor Response by Interleukin-17 Blockade.

Khashayar Esfahani1, Wilson H Miller1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28514612     DOI: 10.1056/NEJMc1703047

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  47 in total

Review 1.  Adverse events associated with immune checkpoint inhibitor treatment for cancer.

Authors:  Khashayar Esfahani; Nicholas Meti; Wilson H Miller; Marie Hudson
Journal:  CMAJ       Date:  2019-01-14       Impact factor: 8.262

Review 2.  A review of cancer immunotherapy: from the past, to the present, to the future.

Authors:  K Esfahani; L Roudaia; N Buhlaiga; S V Del Rincon; N Papneja; W H Miller
Journal:  Curr Oncol       Date:  2020-04-01       Impact factor: 3.677

Review 3.  Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer.

Authors:  Matteo Bellone; Arianna Brevi; Samuel Huber
Journal:  Microbiol Mol Biol Rev       Date:  2020-03-04       Impact factor: 11.056

4.  Mechanistic insights into cancer immunity and immunotherapy.

Authors:  Weiping Zou
Journal:  Cell Mol Immunol       Date:  2018-03-23       Impact factor: 11.530

5.  Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasis.

Authors:  Ryo Hatano; Takumi Itoh; Haruna Otsuka; Sayo Okamoto; Eriko Komiya; Satoshi Iwata; Thomas M Aune; Nam H Dang; Kyoko Kuwahara-Arai; Kei Ohnuma; Chikao Morimoto
Journal:  MAbs       Date:  2019-08-18       Impact factor: 5.857

Review 6.  Role of inflammasome activation in tumor immunity triggered by immune checkpoint blockers.

Authors:  M Segovia; S Russo; M R Girotti; G A Rabinovich; M Hill
Journal:  Clin Exp Immunol       Date:  2020-05       Impact factor: 4.330

Review 7.  Moving towards personalized treatments of immune-related adverse events.

Authors:  Khashayar Esfahani; Arielle Elkrief; Cassandra Calabrese; Réjean Lapointe; Marie Hudson; Bertrand Routy; Wilson H Miller; Leonard Calabrese
Journal:  Nat Rev Clin Oncol       Date:  2020-04-03       Impact factor: 66.675

8.  Hydroxychloroquine is a safe and effective steroid-sparing agent for immune checkpoint inhibitor-induced inflammatory arthritis.

Authors:  Janet Roberts; Michael Smylie; John Walker; Naveen S Basappa; Quincy Chu; Michael Kolinsky; Christopher Lyddell; Carrie Ye
Journal:  Clin Rheumatol       Date:  2019-01-30       Impact factor: 2.980

9.  In Vitro Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness In Vivo.

Authors:  Xiao Hu; Kinga Majchrzak; Xikui Liu; Megan M Wyatt; Chauncey J Spooner; Jacques Moisan; Weiping Zou; Laura L Carter; Chrystal M Paulos
Journal:  Cancer Res       Date:  2018-05-16       Impact factor: 12.701

Review 10.  Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors.

Authors:  David J Lee; Howard J Lee; Jocelyn R Farmer; Kerry L Reynolds
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.